Trial Watch: Immunotherapy plus radiation therapy for oncological indications-Reference-Cited by-同舟云学术

Trial Watch: Immunotherapy plus radiation therapy for oncological indications

Published:2016-07-25 Issue:9 Volume:5 Page:e1214790
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Vacchelli Erika,Bloy Norma,Aranda Fernando,Buqué Aitziber,Cremer Isabelle,Demaria Sandra,Eggermont Alexander,Formenti Silvia Chiara,Fridman Wolf Hervé,Fucikova Jitka,Galon Jérôme,Spisek Radek,Tartour Eric,Zitvogel Laurence,Kroemer Guido,Galluzzi Lorenzo

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.1080/2162402X.2016.1214790

Reference238 articles.

1. Radiation oncology: a century of achievements

2. Past, present, and future of radiotherapy for the benefit of patients

3. Radiation oncology in the era of precision medicine

4. Opportunities and challenges of radiotherapy for treating cancer

5. The role of radiotherapy in cancer treatment

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NAT10-mediated upregulation of GAS5 facilitates immune cell infiltration in non-small cell lung cancer via the MYBBP1A-p53/IRF1/type I interferon signaling axis;Cell Death Discovery;2024-05-18

2. Principles of risk assessment in colon cancer: immunity is key;OncoImmunology;2024-04-30

3. Digital Pathology for Better Clinical Practice;Cancers;2024-04-26

4. Immunotherapy: The Fourth Domain in Oral Cancer Therapeutics;Indian Journal of Otolaryngology and Head & Neck Surgery;2024-03-10

5. In situ vaccination via tissue-targeted cDC1 expansion enhances the immunogenicity of chemoradiation and immunotherapy;Journal of Clinical Investigation;2024-01-02